ArticleLife (Basel, Switzerland)2023

Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study.

Satoshi Shinozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.